Beth Baseler brings more than 35 years in the clinical research and clinical laboratory operations management environment. She holds a bachelor’s degree in biology and a master’s in administration and management. Prior to assuming her current position as the Director of the Clinical Monitoring Research Program Directorate, she held various positions within the Operations and Technical Support Contract for the NCI-Frederick: Director of Administration for the Applied Developmental Research Program, Acting Technical Director of the Biopharmaceutical Development Program, Clinical Services Program Manager, Scientific Program Administrator, and technical laboratory research positions. Baseler has a long history of directing operational and management support to domestic and international clinical studies in all aspects of clinical studies development and management including; regulatory affairs, clinical site development, data monitoring, clinical monitoring, pharmacovigilance, quality assurance and control, protocol navigation, training, project/program management and logistical support. In the last 15+ years, she has directed an expanding operation providing quality programmatic and clinical operations research management support to a variety of high-profile National Cancer Institute and National Institute of Allergy and Infectious Diseases initiatives. A major component of the program provides comprehensive regulatory and clinical trials management support to 400+ domestic and international clinical trials for National Institutes of Health clinical researchers investigating cancer, HIV, and a variety of infectious diseases. More recently, Baseler lead the rapid response to COVID-19 remdesivir trials, the Ebola Response Program in West Africa, and the Vaccine Research Center’s Zika 705 study.